Mostofi FK - Search Results

1

Prediction of prognosis in untreated stage A2 prostatic carcinoma.

Mohler JL, Partin AW, Epstein JI, Becker RL, Mikel UV, Sesterhenn IA, Mostofi FK, Gleason DF, Sharief Y, Coffey DS. Mohler JL, et al. Among authors: mostofi fk. Cancer. 1992 Jan 15;69(2):511-9. doi: 10.1002/1097-0142(19920115)69:2<511::aid-cncr2820690239>3.0.co;2-3. Cancer. 1992. PMID: 1728382

2

A pathologist's view of prostatic carcinoma.

Mostofi FK, Sesterhenn IA, Davis CJ Jr. Mostofi FK, et al. Cancer. 1993 Feb 1;71(3 Suppl):906-32. doi: 10.1002/1097-0142(19930201)71:3+<906::aid-cncr2820711407>3.0.co;2-i. Cancer. 1993. PMID: 7679044 Review.

3

Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.

Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW. Heidenreich A, et al. Among authors: mostofi fk. Cancer. 1998 Sep 1;83(5):1002-11. Cancer. 1998. PMID: 9731905

4

Incidence and clinical significance of high-grade prostatic intraepithelial neoplasia in TURP specimens.

Gaudin PB, Sesterhenn IA, Wojno KJ, Mostofi FK, Epstein JI. Gaudin PB, et al. Among authors: mostofi fk. Urology. 1997 Apr;49(4):558-63. doi: 10.1016/s0090-4295(96)00542-0. Urology. 1997. PMID: 9111625 Clinical Trial.

5

Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients.

Douglas TH, Morgan TO, McLeod DG, Moul JW, Murphy GP, Barren R 3rd, Sesterhenn IA, Mostofi FK. Douglas TH, et al. Among authors: mostofi fk. Cancer. 1997 Jul 1;80(1):107-14. doi: 10.1002/(sici)1097-0142(19970701)80:1<107::aid-cncr14>3.0.co;2-1. Cancer. 1997. PMID: 9210715

6

The molecular characteristics of bladder cancer in young patients.

Linn JF, Sesterhenn I, Mostofi FK, Schoenberg M. Linn JF, et al. Among authors: mostofi fk. J Urol. 1998 May;159(5):1493-6. doi: 10.1097/00005392-199805000-00022. J Urol. 1998. PMID: 9554340

7

Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.

Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C. Hsing AW, et al. Among authors: mostofi fk. Cancer Res. 2000 Sep 15;60(18):5111-6. Cancer Res. 2000. PMID: 11016637

8

Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.

Chokkalingam AP, McGlynn KA, Gao YT, Pollak M, Deng J, Sesterhenn IA, Mostofi FK, Fraumeni JF Jr, Hsing AW. Chokkalingam AP, et al. Among authors: mostofi fk. Cancer Res. 2001 Jun 1;61(11):4333-6. Cancer Res. 2001. PMID: 11389055

9

Pathology of carcinoma of the prostate.

Mostofi FK, Davis CJ Jr, Sesterhenn IA. Mostofi FK, et al. Cancer. 1992 Jul 1;70(1 Suppl):235-53. doi: 10.1002/1097-0142(19920701)70:1+<235::aid-cncr2820701311>3.0.co;2-g. Cancer. 1992. PMID: 1376194 Review.

10

Prostatic carcinoma: problems in the interpretation of prostatic biopsies.

Mostofi FK, Sesterhenn IA, Davis CJ Jr. Mostofi FK, et al. Hum Pathol. 1992 Mar;23(3):223-41. doi: 10.1016/0046-8177(92)90103-a. Hum Pathol. 1992. PMID: 1555834 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters